Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.

Last updated: November 6, 2024
Sponsor: Polyclinique Bordeaux Nord Aquitaine
Overall Status: Active - Recruiting

Phase

N/A

Condition

Birth Defects

Blood Clots

Holoprosencephaly

Treatment

Control Group

ARISTA

Clinical Study ID

NCT05323448
2022-ORT01
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to assess the efficacy of the ARISTA AH for restoring hemostasis following a long segment posterior spinal fusion.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patient eligible to a posterior lumbar or thoraco-lumbar long-segment spinal fusion.

  2. Surgery targeting at least 5 adjacent vertebra combined with one of the followingprocedure:

  3. Intersomatic bone graft;

  4. Pedicle substraction osteotomy;

  5. Any other intervertebral osteotomy (e.g. Smith-Petersen osteotomy);

  6. The use of a surgical drain inserted at the operative site is mandatory (suctiondrain and other drain are eligible);

Exclusion

Exclusion Criteria:

  1. Subject under the age of 18 years old;

  2. Subject with a known haemostatic disorder;

  3. Subject with any infection or any immune system disorder;

  4. Subject not eligible to a posterior spinal surgery;

  5. Subject with a known allergy or any contraindication to the use of the study device;

  6. Currently pregnant or planning pregnancy;

  7. Prisoner or a ward of the state;

  8. Subject no willing to participate in the study;

  9. Subject not affiliated to a social security insurance.

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Control Group
Phase:
Study Start date:
October 25, 2022
Estimated Completion Date:
February 01, 2025

Study Description

After being informed about the study and potential risks, all patients giving written inform consent will be included in the study during their preoperative visit. After eligibility criteria checking and based on their respective surgical indication, participants will be randomized in a single-blinded and stratified manner (participant only) in a 1:1 ratio to ARISTA-AH or no ARISTA-AH. The stratification process will consider the number of instrumented vertebra during each surgery (level 1: 5 to 8 vertebra; level 2: 9 or more instrumented vertebra).

Connect with a study center

  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, 33077
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.